Skip to main content

Platelet-rich plasma for foot and ankle disorders in the athletic population

Publication ,  Journal Article
Delos, D; Murawski, CD; Kennedy, JG; Rodeo, SA
Published in: Techniques in Foot and Ankle Surgery
March 1, 2011

Athletes and their physicians are constantly searching for ways to heal injuries faster and allow for a quicker return to activity and sport. However, reliable and effective means of treating foot and ankle tendon/ligament disorders as well as fracture nonunions, and osteochondral lesions of the talus are limited. In the past, rest/immobilization, corticosteroids/nonsteroidal anti-inflammatory drugs, and rehabilitation were the mainstays of nonoperative treatment. However, results were inconsistent. In addition, anti-inflammatory medications and corticosteroids have been associated with potentially serious side effects. Recently, platelet-rich plasma (PRP) has been heralded as a safe, new therapy with potential for treating both soft and mineralized tissue injuries throughout the body, including the foot and ankle. PRP is a concentrated solution of platelets and other buffy coat elements in plasma that can be activated by collagen or thrombin and calcium. Platelets are known to be rich in growth factors and cytokines that are involved in the healing response, such as platelet-derived growth factor, vascular endothelial growth factor, insulin-like growth factor-1, and transforming growth factor-β. Early reports showed positive results leading to increasingly greater interest. Currently, we recommend using PRP only for injuries/lesions of the foot and ankle that have failed standard therapies. Before use, a thorough history and physical examination should be performed, including a detailed history of allergies and blood disorders. For maximum benefit with minimal risk of complications, injections should be performed under image guidance. Despite the great potential associated with it, evidence regarding the efficacy of PRP has been primarily limited to small case series and anecdotal reports. More rigorous analyses, preferably randomized controlled studies, are needed before PRP may be adopted as a standard therapeutic modality. Copyright © 2011 by Lippincott Williams & Wilkins.

Duke Scholars

Published In

Techniques in Foot and Ankle Surgery

DOI

EISSN

1538-1943

ISSN

1536-0644

Publication Date

March 1, 2011

Volume

10

Issue

1

Start / End Page

11 / 17

Related Subject Headings

  • Orthopedics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Delos, D., Murawski, C. D., Kennedy, J. G., & Rodeo, S. A. (2011). Platelet-rich plasma for foot and ankle disorders in the athletic population. Techniques in Foot and Ankle Surgery, 10(1), 11–17. https://doi.org/10.1097/BTF.0b013e31820b9938
Delos, D., C. D. Murawski, J. G. Kennedy, and S. A. Rodeo. “Platelet-rich plasma for foot and ankle disorders in the athletic population.” Techniques in Foot and Ankle Surgery 10, no. 1 (March 1, 2011): 11–17. https://doi.org/10.1097/BTF.0b013e31820b9938.
Delos D, Murawski CD, Kennedy JG, Rodeo SA. Platelet-rich plasma for foot and ankle disorders in the athletic population. Techniques in Foot and Ankle Surgery. 2011 Mar 1;10(1):11–7.
Delos, D., et al. “Platelet-rich plasma for foot and ankle disorders in the athletic population.” Techniques in Foot and Ankle Surgery, vol. 10, no. 1, Mar. 2011, pp. 11–17. Scopus, doi:10.1097/BTF.0b013e31820b9938.
Delos D, Murawski CD, Kennedy JG, Rodeo SA. Platelet-rich plasma for foot and ankle disorders in the athletic population. Techniques in Foot and Ankle Surgery. 2011 Mar 1;10(1):11–17.

Published In

Techniques in Foot and Ankle Surgery

DOI

EISSN

1538-1943

ISSN

1536-0644

Publication Date

March 1, 2011

Volume

10

Issue

1

Start / End Page

11 / 17

Related Subject Headings

  • Orthopedics